We found no significant differences in homocysteine levels and the proportion of patients with hyperhomocysteinemia between the subgroups of homozygous carriers, heterozygous carriers, and non-carriers of MTHFR 677 among cases. This evidence concerns the gene MTHFR and hyperhomocysteinemia.